Tag: Charles Ornstein
Charles Ornstein: Government Will Withhold One-Third of the Records from Database of Physician PaymentsAugust 2014
Many payments to doctors made by pharmaceutical companies will not be included in the public release of the database next month.
Charles Ornstein: The Shutdown of the Pharma Payment Verification SystemAugust 2014
The government had to take offline its system for doctors to verify payments from drug companies.
Charles Ornstein: Medicare Billing Outliers Often Have Disciplinary Problems, TooJune 2014
Medicare finds financial oversight associated with more serious problems.
Charles Ornstein: Medicare Overpays BillionsMay 2014
The findings by the inspector general of the U.S. Department of Health and Human Services indicate that many doctors bill for services very differently than their peers.
Charles Ornstein: Medicaid Programs Drowning in BacklogApril 2014
There are growing signs that Obamacare's Medicaid expansion is a victim of its own success, unable to keep up with demand.
Charles Ornstein: More Tools, Beyond Ratings, To Pick Your DoctorApril 2014
Doctor familiarity without the wire taps.
Charles Ornstein: Leaders of Teaching Hospitals Have Close Ties to Drug CompaniesApril 2014
Nearly every large drug maker based in the United States had at least one academic medical center official on its board, raising questions about their independence.
Charles Ornstein: Double Dip: Doctors Paid to Advise, Promote Drug Companies That Fund Their ResearchMarch 2014
The conflict of interest between pharmaceuticals and clinical trials.
Charles Ornstein: Ad Endorsing da Vinci Robot Violated U of Illinois PoliciesMarch 2014
When surgical team members endorsed the robot in an ad, controversy ensued.
Charles Ornstein: When a University Hospital Backs a Surgical Robot, Controversey EnsuesFebruary 2014
Should an entire hospital department help advertise a medical robot?
Charles Ornstein: Some Predictions on How Medicare Will Release Physician Payment DataJanuary 2014
The government’s announcement that it will begin releasing the data seems to have ticked off both supporters and opponents of broader transparency in medicine.
Charles Ornstein: Obamacare – A Midterm Report CardJanuary 2014
How the Affordable Care Act is faring after the first half of the open enrollment period.
Tracy Weber and Charles Ornstein: Medicare Wants Power to Ban Harmful PrescribersJanuary 2014
From Plan B to Part D, another controversial medical scenario.
Tracy Weber and Charles Ornstein: Caught Up in a Medicare FraudJanuary 2014
Either Joyce Heap was being given expensive medications for conditions she didn't have or something sinister was going on.
Charles Ornstein: Payment DueDecember 2013
The Obamacare deadline no one is talking about.
Charles Ornstein: Six Questions About HealthCare.gov’s FutureDecember 2013
Will the improvements to the site be enough to ensure consumers can get coverage before the December 23 deadline?
Charles Ornstein and Tracy Weber: Generic or Name Brand?November 2013
With billions in potential savings for Medicare at stake, we asked drug experts and practitioners alike why more doctors don't recommend generics when they can.
Charles Ornstein: Brushes with the Medical SystemNovember 2013
Four journalists describe how their own experiences with the health-care system has affected their reporting.
Charles Ornstein: Why Two Obama Loyalists Lost Their Health PoliciesNovember 2013
Two casualties of the transitioning American healthcare system.
Charles Ornstein: Health Policy Canceled?November 2013
What we know and don’t know about Obamacare’s effect on individual health insurance policies.
Tracy Weber and Charles Ornstein: Why You Should Care About the Drugs Your Doctor PrescribesJuly 2013
When taking prescription drugs, a lot is left unknown.
Tracy Weber, Charles Ornstein and Jennifer LaFleur: ‘Extreme’ PrescribersJune 2013
An Inspector General's report faults Medicare for not tracking abuses in prescriptions.
Tracy Weber and Charles Ornstein: Dollars for Docs Mints a MillionaireMarch 2013
A Nashville psychiatrist becomes the first physician to net $1 million in promotional-speaking fees from drug companies.
Charles Ornstein: How Mom’s Death Changed My Thinking About End-of-Life CareMarch 2013
A veteran health reporter reflects on Medicare spending and family's hospital decision-making.
Kim Barker: Two Dark Money Groups Outspending All Super PACs CombinedAugust 2012
Two conservative non-profits have poured $60 million into the presidential race, far outspending the super-PACS.